Open label, pilot evaluation of the safety and efficacy of Intravesical sustained release system of lidocaine and oxybutynin (TRG-100) for patients with interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive bladder (OAB) and patients with retained ureteral stents following Endourological interventions (EUI)

This study assessed the safety and efficacy of TRG-100 in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), overactive bladder (OAB) and endourological intervention stented (EUI) patients in an open-label, prospective study.

Source: Urology - May 31, 2023 Category: Urology & Nephrology Authors: Galiya Raisin, David Dothan, Dolev Perez, Natshe Ala-Adin, Ilan Kafka, Ofer Shenfeld, Shira Hatumi, Nadav Malchi, Avi Gordon, Dan Touitou, Robert Moldwin, Taher Nassar, Boris Chertin Source Type: research